NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia pronounced (mab-thir-ra) contains the active ingredient rituximab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MabThera intravenous infusion.It […]
Aloxi
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALOXI® Palonosetron 250 microgram per 5 mL solution for injection; Palonosetron 75 microgram per 1.5 mL solution for injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ALOXI. It does not contain all the available […]
Carboplatin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CARBOPLATIN INJECTION Carboplatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Carboplatin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All […]
New weapon in battle with cancer caused by asbestos
Patients in battle with deadly asbestos lung cancer are living longer, healthier lives thanks to breakthrough immune-boosting drug Trial shows drug nivolumab can keep disease at bay for months or even years Extra time can be priceless as seven per cent of sufferers live over five years Most of those with mesothelioma are given chemotherapy which stops […]
Onivyde
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ONIVYDE Nanoliposomal irinotecan – Irinotecan 4.3 mg/mL concentrate for solution for infusion Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ONIVYDE. It does not contain all of the available information. All medicines have risks and […]
Evifyne
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EVIFYNE® V11219 Raloxifene hydrochloride Consumer Medicine Information What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine.It does not contain all the available information and does not take the place of […]
Hexaxim
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. HEXAXIM® DTPa-hepB-IPV-Hib Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) Consumer Medicine Information What is in this leaflet Read all of this leaflet carefully before your child is vaccinated. Keep this leaflet. […]
APO-Olanzapine
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-OLANZAPINE FILM COATED TABLETS Olanzapine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or […]
Provera
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PROVERA® Medroxyprogesterone acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PROVERA.It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist. All medicines have risks […]
Faslodex
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FASLODEX® fulvestrant Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about FASLODEX. It does not contain all the information that is known about FASLODEX. It does not take the place of talking […]